← Eichor
Study identifier: NCT06967727 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Registry and Natural History of Epilepsy-Dyskinesia Syndromes

Condition: Epilepsy-Dyskinesia · Epilepsy · Dyskinesia  ·  Sponsor: Boston Children's Hospital

PhaseN/A
Planned participants700
Who can joinAll sexes, 0 Years to 30 Years
Healthy volunteersNo

About this study

The Registry and Natural History of Epilepsy-Dyskinesia Syndromes is focused on gathering longitudinal clinical data as well as biological samples (blood, urine, and/or skin/tissue) from male and female patients, of all ages, who have a genetic diagnosis of epilepsy-dyskinesia syndromes. Through prospective review and molecular data analysis, the study aims to identify patterns and correlations between movement and seizure disorders, uncovering genotype-phenotype relationships. The initiative's goals are to enhance understanding of epilepsy-dyskinesia syndromes, inform precision medicine approaches, and foster international collaboration.

This description comes directly from the study's public registry record.

Talk to the study team

Darius Ebrahimi-Fakhari, MD, PhD  ·  617-355-0097  ·  movementdisorders@childrens.harvard.edu

Josh Rong, BS  ·  617-355-0903  ·  movementdisorders@childrens.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Boston Children's HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06967727